JPS4949582B1 - - Google Patents
Info
- Publication number
- JPS4949582B1 JPS4949582B1 JP401469A JP401469A JPS4949582B1 JP S4949582 B1 JPS4949582 B1 JP S4949582B1 JP 401469 A JP401469 A JP 401469A JP 401469 A JP401469 A JP 401469A JP S4949582 B1 JPS4949582 B1 JP S4949582B1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Control Of Resistance Heating (AREA)
- Control Of Temperature (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP401469A JPS4949582B1 (pt) | 1969-01-20 | 1969-01-20 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP401469A JPS4949582B1 (pt) | 1969-01-20 | 1969-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS4949582B1 true JPS4949582B1 (pt) | 1974-12-27 |
Family
ID=11573100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP401469A Pending JPS4949582B1 (pt) | 1969-01-20 | 1969-01-20 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS4949582B1 (pt) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10905690B2 (en) | 2014-01-21 | 2021-02-02 | Neurocrine Biosciences, Inc. | Treatment of congenital adrenal hyperplasia |
-
1969
- 1969-01-20 JP JP401469A patent/JPS4949582B1/ja active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10905690B2 (en) | 2014-01-21 | 2021-02-02 | Neurocrine Biosciences, Inc. | Treatment of congenital adrenal hyperplasia |
| US11311544B2 (en) | 2014-01-21 | 2022-04-26 | Neurocrine Biosciences, Inc. | Treatment of congenital adrenal hyperplasia |
| US11730739B2 (en) | 2014-01-21 | 2023-08-22 | Neurocrine Biosciences, Inc. | Treatment of congenital adrenal hyperplasia |